Table 1 Clinical data
From: GCH1-polymorphism and pain sensitivity among women with provoked vestibulodynia
Variables | Patients | Controls | p-value |
|---|---|---|---|
|  | (n = 98) | (n = 102) |  |
Current age, years | 29 (19–44) | 24 (18–35) | <0.001 |
Duration of PVD, years | 8 (0,5-18) | - | - |
Primary PVD | 35 (36%) | - | - |
Secondary PVD | 63 (64%) | - | - |
Current use of hormonal contraceptives | 33 (34%) | 53 (52%) | 0.005 |
Combined hormonal contraceptives | 26 (27%) | 42 (40%) | ns |
Progestogen only contraceptives | 7 (7%) | 11 (11%) | ns |
Menstrual cycle day | 7.9 (4–13) | 8.0 (3–13) | ns |
Concomitant pain | Â | Â | Â |
Dysmenorrhea | 67 (71%) | 55 (54%) | 0.02 |
Headache | 59 (60%) | 30 (29%) | <0.001 |
GI pain and dysfunction | 53 (54%) | 22 (22%) | <0.001 |
Back pain | 48 (49%) | 20 (20%) | <0.001 |
Muscle pain | 31 (32%) | 2 (2%) | <0.001 |
Other pain | 26 (27%) | 1 (1%) | <0.001 |